Navigation Links
Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
Date:8/23/2010

rially from what is expressed in, or implied by, these statements. Soligenix cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including orBec®, SGX201, RiVax™, and LPM™, particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will not exceed projected levels, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be able to successfully obtain any further grants and awards, maintain its existing grants which are subject to performance, enter into any biodefense procurement contracts with the US Government or other countries, that the US Congress may not pass any legislation that would provide additional funding for the Project BioShield program, that it will be able to patent, register or protect its technology from challenge and products from competition or maintain or expand its license agreements with its current licensors, or that its business strategy will be successful. Important factors which may affect the future use of orBec® for gastrointestinal GVHD include the risks that: the FDA's requirement that Soligenix conduct additional clinical trials to demonstrate the safety and efficacy of orBec® will take a significant amount of time and money to complete and positive results leading to regulatory approval cannot be assumed; Soligenix is dependent on the expertise, effort, priorities and contractual obligations of third parties in the clinical trials, manufacturing, marketing, sales and distribution of its products; orBec® may not gain market acceptance if it is eventually approved by the FDA;
'/>"/>
SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
6. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
7. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 Auxilium ... specialty biopharmaceutical company, today announced that its Board ... non-binding and conditional proposal from Endo International plc ... and legal advisors, has unanimously determined it is ... its existing merger agreement with QLT Inc. ("QLT") ...
(Date:9/20/2014)... /CNW/ - The issue: Mylan Pharmaceuticals ULC Canada, in consultation ... Mylan-Nitro Spray 0.4 mg/metered dose due to the product missing ... A missing "dip tube" could pose a ... This defect may lead patients to believe they are receiving ... it. Not receiving nitroglycerin could place them at risk for ...
(Date:9/19/2014)... 19, 2014 A pharmaceutical executive in the ... three issues he wanted the research and consulting firm ... personnel (especially for secondary research) to maximize efficiency and ... increased workload , Automation of market research processes ... , How to implement and manage those automated systems ...
Breaking Medicine Technology:Auxilium Provides Transaction Update 2Auxilium Provides Transaction Update 3Auxilium Provides Transaction Update 4Auxilium Provides Transaction Update 5Auxilium Provides Transaction Update 6Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2
... The complex cases performed,during this month,s ... Das, an interventional cardiologist at Presbyterian,Hospital of ... vascular,disease, a looming health concern as the ... heart disease. The country,s obesity epidemic will ...
... Calif., Oct. 26 Accuray,Incorporated (Nasdaq: ARAY ... radiosurgery,announced today that the company is partnering with ... in Houston, Texas to launch a prospective,clinical study ... Patients in the study will be randomly assigned ...
Cached Medicine Technology:Cardiologists Tackle 'Next Frontier' in Cardiovascular Disease 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 3M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 4
(Date:9/22/2014)... Pain does not need to rule your life ... reader-friendly book designed to guide the individual who suffers with ... book is written to help the reader who is struggling ... regain a pain-free life — a daily “go-to” guide on ... pain has become an epidemic, with over 100 million Americans ...
(Date:9/22/2014)... YORK (September 22, 2014) Montefiore Medical Center, Albert Einstein ... Women,s Hospital have received a $300,000 grant from The ... the impact of health Information Technology (IT) on patient ... electronic orders, an important clinical patient safety issue impacted ... will be the first time IT leaders have data ...
(Date:9/22/2014)... of flavonoid found in hops and beer, has been ... in young mice, but not in older animals. , ... Research by scientists from the Linus Pauling Institute ... It,s another step toward understanding, and ultimately reducing the ... mammalian species, including humans. , Flavonoids are compounds found ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Medical ... for a three-day conference to discuss brain-related diseases ... injury from concussions and neurodegenerative disorders. , ... director affiliated with a Silverado memory care community ... dedicated expertise in memory care, hosts the annual ...
(Date:9/22/2014)... North Carolina at Chapel Hill researchers represents an important ... are experiencing the earliest stages of psychosis. , Psychosis ... severe mental disorders such as schizophrenia. Schizophrenia emerges in ... in every 100 people. In severe cases, the impact ... and the burden on family members can be almost ...
Breaking Medicine News(10 mins):Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2Health News:AHRQ grant awarded to study the impact of health IT on patient safety at Montefiore and Einstein and Brigham and Women's Hospital 2Health News:Compound from hops aids cognitive function in young animals 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 3Health News:Blood test may help determine who is at risk for psychosis 2
... -CTA Acceptance in the Netherlands Triggers Milestone Payment ... Radius Health ("Radius"),announced today that the Dutch regulatory ... RAD1901, Radius, novel,tissue-selective SERM (selective estrogen receptor modulator) ... to begin a Phase I,clinical trial of RAD1901 ...
... Thanks to Nutrition on the Go, an,innovative new program ... more than 1,700 restaurants nationwide is available in,a flash through ... and menu item., Not cell phone savvy? No worries. ... menu item you need help with, then send that info ...
... LANCASTER, Pa., Jan. 30 Members of Highmark,s,FreedomBlue ... care options. Effective immediately, both routine and emergency,medical ... and Lancaster,Regional hospitals., "We,re pleased to partner ... and high-quality health care to people with Medicare ...
... CHESTER, N.J. and SLOUGH, England, Jan. 30 ... the,successful completion of its acquisition of Adams Respiratory ... cash tender offer followed by a,short- form merger ... and into Adams. As a result of this ...
... (OTC Bulletin,Board: NTRZ) announced today that it has filed ... U.S. Securities and Exchange,Commission (SEC). If and when declared ... offer and sell under the universal shelf registration,statement up ... preferred,stock, depositary shares and/or warrants to purchase any of ...
... Jan. 30 EMH Regional Healthcare System has,selected ... increasing bad debt and streamline administration of its ... is a 434-bed, non-profit hospital,system with campuses in ... the,EMH Regional Healthcare System has served the needs ...
Cached Medicine News:Health News:Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes 2Health News:Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes 3Health News:Ring Up Instant Nutrition Info via Text Message to DIET1 (34381) 2Health News:Heart of Lancaster and Lancaster Regional Join Highmark Blue Shield Medicare Advantage Network 2Health News:Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc. 2Health News:NutraCea Files Universal Shelf Registration Statement 2Health News:EMH Regional Medical Center Selects TransUnion's Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 2Health News:EMH Regional Medical Center Selects TransUnion's Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 3
... 150 watt halogen light ... , ,SOLOS Endoscopy shares ... patient with the highest quality ... research and development of advanced ...
... first for Linvatec! The EnVision Autoclavable ... and proprietary technology to ensure true ... Shockflex prism system gives our customers ... their investment. With an integrated multi-specialty ...
... surgery is founded on superior medical video ... 3-Chip cameras, 1-Chip cameras, Light sources, Couplers ... demanding needs., ,Superior resolution and color ... 3-Chip cameras, and are the benchmark by ...
... System provides easy-to-use features, auto iris, white ... camera head construction is based on Solos ... 1-Chip Camera System, Domestic (GS 9960-NTSC) includes: ... with power cord and video cables , ...
Medicine Products: